ePrints

Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association

Lookup NU author(s): Dr Petros PerrosORCiD

Downloads

• Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Abstract

Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for hyperthyroidism and under the care of endocrinologists. Endocrinologists, therefore, have a key role in diagnosis, initial management, and selection of patients who require referral to specialist care. Given that the need for guidance to endocrinologists charged with meeting the needs of patients with TED transcends national borders, and to maximize an international exchange of knowledge and practices, the American Thyroid Association and European Thyroid Association joined forces to produce this consensus statement.

Publication metadata

Author(s): Burch HB, Perros P, Bednarczuk T, Cooper DS, Dolman PJ, Leung AM, Mombaerts I, Salvi M, Stan MN

Publication type: Article

Publication status: Published

Journal: Thyroid

Year: 2022

Volume: 32

Issue: 12

Pages: 1439-1470

Online publication date: 13/12/2022

Acceptance date: 02/04/2018

Date deposited: 12/01/2023

ISSN (print): 1050-7256

ISSN (electronic): 1557-9077

Publisher: Mary Ann Liebert, Inc.

URL: https://doi.org/10.1089/thy.2022.0251

DOI: 10.1089/thy.2022.0251

PubMed id: 36480280

Altmetrics

Share